Skip to main content

AgoraSign in

Shelley Mayer

Sponsor · State Senator, District 37 · Democratic/Working Families

Follow

Senate bill · S8656 (2025-26)

Relates to the dispensing of certain prescriptions

Latest action Mar 6, 2026

Summary

Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.

Your position on this bill

Not chosen yet

Sign in to choose

Where it stands

Passed one of the two chambers; it still needs the other.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

New York State Senate

Same as A10428, the matching bill in the Assembly.

Amends the Education Law.

Committee

Higher Education · New York State Assembly

Also referred to Higher Education · New York State Senate.

Purpose, from the sponsor's memo

To allow providers prescribing medication abortion to request that the pharmacy exclude certain identifying information on prescription labels, or if they dispense the drugs themselves, allow them to exclude such information.

Filed with the bill. Read it on nysenate.gov (opens in a new tab)

Recorded votes

  • Vote: Floor vote

    NY SenateJan 27, 2026Result: passed

    (37) (21) (0) (3)
  • Vote: Committee vote · Higher Education

    Senate Higher EducationJan 20, 2026Result: passed

    (13) (6) (0) (1)

The sponsor's argument

Why Shelley Mayer says this is needed

Since the Supreme Court's disastrous decision to revoke the constitu- tional right to an abortion in Dobbs vs. Jackson Women's Health Organ- ization in June 2022, states around the country have moved to restrict access to abortion. As of November 2024, nineteen states ban abortion under twelve weeks. Thirteen of those states have functionally a full ban; another four ban abortion after 6 weeks, when few women even know they are pregnant.' Over half of women between the ages of 18-49 live in a state with some restrictions on abortion care.2 Medication abortion has become a lifeline for many individuals seeking abortions in hostile states. In 2023, New York passed a telehealth shield law (Chapter 138 of the laws of 2023) to provide broad protection to doctors based in New York serving patients in those states via tele- health. These protections include shielding New York health care practi- tioners against states that may try to impose civil or criminal sanc- tions upon them and protection from professional disciplinary action or adverse action from medical malpractice insurers. Thanks to New York's shield law, providers based in New York are able to send thousands of abortion pills to patients based in hostile states each month, helping women who may not otherwise be able to access abortion care. According to research by the Society for Family Planning, in the first six months of 2025, 2796- of abortions nationally were provided via telehealth. In states where abortion is banned, telehealth makes up nearly 100% of abortions. (A small number are provided under exceptions to some state laws). As of June 2025, the Society for Family Planning estimates that 55% of telehealth abortions are being provided from states with shield laws like New York's.3 In response to escalating threats to telehealth providers, in 2025 New York strengthened its telehealth shield law, including by allowing phar- macies and prescribers filling prescriptions to use the name of the prescribing doctor's practice rather than their name on the prescription label (Chapter 7 of the laws of 2025). Unfortunately, attacks on provid- ers serving women through telehealth have only increased since then. This legislation provides further protections for providers and patients taking advantage of telehealth care. It would allow prescribers to request that a pharmacy exclude their name and the name and address of the patient and pharmacy when filling a prescription for medication abortion. Similarly, doctors dispensing medication abortion would be allowed to exclude their and their patient's name and address from the prescription label. Pharmacies and doctors would be required to keep records of their prescriptions for five years which would be subject to the existing protections of New York's shield law. Similar protections were adopted by California in September of 2025 (Chapter 136 of California's laws of 2025).

This is the sponsor's own case for the bill, quoted from their memorandum. It is not Agora's description of what the bill does.

Full history

  1. Mar 6, 2026

    Referred to committee

    REFERRED TO HIGHER EDUCATION

    NY Assembly

  2. Mar 3, 2026

    Enacting Clause Stricken

    ENACTING CLAUSE STRICKEN

    NY Assembly

  3. Jan 30, 2026

    Referred to committee

    REFERRED TO HIGHER EDUCATION

    NY Assembly

  4. Jan 27, 2026

    Sent to the executive

    DELIVERED TO ASSEMBLY

    NY Senate

  5. Jan 27, 2026

    Passed a chamber

    PASSED SENATE

    NY Senate

Show full history (5 earlier events)
  1. Jan 27, 2026

    Referred to committee

    REFERRED TO HIGHER EDUCATION

    NY Assembly

  2. Jan 20, 2026

    Ordered to Third Reading CAL.60

    ORDERED TO THIRD READING CAL.60

    NY Senate

  3. Jan 20, 2026

    Reported out of committee

    REPORTED AND COMMITTED TO RULES

    NY Senate

  4. Jan 14, 2026

    Amend and Recommit to Higher Education

    AMEND AND RECOMMIT TO HIGHER EDUCATION

    NY Senate

  5. Jan 7, 2026

    Referred to committee

    REFERRED TO HIGHER EDUCATION

    NY Senate

About this record

Summary

The summary comes from NY Open Legislation, the New York State Senate's public record. For more, see How we handle summaries.

Cosponsors

The list shows the cosponsors who are on Agora, A to Z. The official record may list more.

Party colors

Parties are shown in the same neutral colors.

Source

From NY Open Legislation, the NY Senate and Assembly, and official rosters. This record was last updated Nov 4, 2026. About our data

Read the record

Follow